Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection

Alissa Visram, Dirk Larson, Aaron D Norman, Angela Dispenzieri, David L Murray, Robert A Kyle, S. Vincent Rajkumar, Susan L. Slager, Shaji K Kumar, Celine M. Vachon

Blood blood.2024025415.

https://doi.org/10.1182/blood.2024025415

Published: 2024

Includes: Supplemental data

Journal Articles

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Blood (2023) 142 (Supplement 1): 2990.

https://doi.org/10.1182/blood-2023-182266

Published: 2023

Journal Articles

Mosaic Chromosomal Alterations and Monoclonal B-Cell Lymphocytosis: Relationship and Risk of Hematologic Malignancies

Rosalie Griffin, Aswin Sekar, Sameer A. Parikh, Giulio Genovese, Dennis P. Robinson, Aaron D. Norman, Janet E. Olson, Kari G. Rabe, Nicholas J. Boddicker, Paul J. Hampel, Neil E. Kay, Timothy G. Call, James R. Cerhan, Esteban Braggio, Curtis A. Hanson, Caline M. Vachon, Tait D. Shanafelt, Benjamin L. Ebert, Susan L. Slager

Blood (2023) 142 (Supplement 1): 2690.

https://doi.org/10.1182/blood-2023-184696

Published: 2023

Journal Articles

Progression and survival of MBL: a screening study of 10 139 individuals

Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Aaron D. Norman, Kari G. Rabe, Nicholas J. Boddicker, Janet E. Olson, Geffen Kleinstern, Connie E. Lesnick, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait D. Shanafelt

Blood (2022) 140 (15): 1702–1709.

https://doi.org/10.1182/blood.2022016279

Published: 2022

Includes: Supplemental data

Journal Articles

Prevalence and Overall Survival of Low Count Monoclonal B-Cell Lymphocytosis (LC-MBL): A Screening Study of 8,297 Individuals from the Mayo Clinic Biobank

Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Geffen Kleinstern, Nicholas J. Boddicker, Aaron D. Norman, Kari G. Rabe, Connie E. Lesnick, Timothy G. Call, Janet E. Olson, James R. Cerhan, Neil E. Kay, Celine M. Vachon, Esteban Braggio, Curtis A. Hanson, Tait Shanafelt

Blood (2021) 138 (Supplement 1): 2632.

https://doi.org/10.1182/blood-2021-153320

Published: 2021

Journal Articles

Relationship and Susceptibility to Serious Infections Among Monoclonal B-Cell Lymphocytosis (MBL), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Clonal Hematopoiesis (CH) Premalignant Conditions

Nicholas J. Boddicker, Sameer A. Parikh, Geffen Kleinstern, Aaron D. Norman, Kari G. Rabe, Timothy G. Call, Janet E. Olson, Angela Dispenzieri, David L Murray, S. Vincent Rajkumar, Shaji Kumar, James R. Cerhan, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait Shanafelt, Celine M. Vachon, Susan L. Slager

Blood (2021) 138 (Supplement 1): 3739.

https://doi.org/10.1182/blood-2021-151929

Published: 2021

Journal Articles

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Blood (2021) 137 (15): 2046–2056.

https://doi.org/10.1182/blood.2020006322

Published: 2021

Includes: Supplemental data

Journal Articles

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Geffen Kleinstern, PhD, J. Brice Weinberg, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Dennis P. Robinson, Aaron D. Norman, MPH, Kari G Rabe, Celine M. Vachon, PhD, Connie E. Lesnick, Timothy G. Call, MD, Danielle M. Brander, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Richard R. Furman, MD, Tait Shanafelt, MD, Susan L. Slager, PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136548

Published: 2020

Journal Articles

Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)

Celine M. Vachon, PhD, Josiah Murray, Cristine Allmer, BS, Dirk Larson, MS, Aaron D. Norman, MPH, Jason P Sinnwell, MS, Angela Dispenzieri, MD, Geffen Kleinstern, PhD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Susan L. Slager, PhD, Shaji K. Kumar, MD, David L. Murray, MDPhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-142583

Published: 2020

Journal Articles

Body Mass Index and Clinical Factors Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Progression in Olmsted County, Minnesota

Geffen Kleinstern, PhD, Dirk Larson, MS, Cristine Allmer, BS, Aaron D. Norman, MPH, Jason P Sinnwell, MS, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Robert A. Kyle, MD, Susan L. Slager, PhD, Shaji K. Kumar, MD, Celine M. Vachon, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-136894

Published: 2020

Journal Articles

Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

Geffen Kleinstern, PhD, Daniel R O'Brien, Brian Kabat, B.S., Kari G Rabe, Aaron D. Norman, Huihuang Yan, PhD, Celine M. Vachon, PhD, Shulan Tian, MS, PhD, Timothy G. Call, MD, Sameer A. Parikh, MD, Jose F. Leis, MD PhD, Wei Ding, MD PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Esteban Braggio, PhD, Susan L. Slager, PhD

Blood (2019) 134 (Supplement_1): 852.

https://doi.org/10.1182/blood-2019-124346

Published: 2019

Journal Articles

Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival

Blood (2019) 134 (Supplement_1): 4366.

https://doi.org/10.1182/blood-2019-126088

Published: 2019

Journal Articles

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)

Nicholas J Boddicker, PhD, Daniel R O'Brien, Esteban Braggio, PhD, Sara J. Achenbach, Kari G. Chaffee, MS, Aaron D. Norman, Celine M. Vachon, PhD, Brian Kabat, B.S., Timothy G. Call, MD, Sameer A. Parikh, MD, Jose F. Leis, MD PhD, Wei Ding, MD PhD, Eli Muchtar, MD, James R. Cerhan, MD PhD, Tait D. Shanafelt, MD, Neil E. Kay, MD, Neil E Caporaso, Susan L. Slager, PhD

Blood (2018) 132 (Supplement 1): 3116.

https://doi.org/10.1182/blood-2018-99-117044

Published: 2018

Journal Articles

Large-Scale Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Families

Alyssa I. Clay-Gilmour, BS, PhD, Nicola J Camp, PhD, Xiaomu Wei, PhD, Aaron D. Norman, Jason P Sinnwell, MS, Delphine Demangel, Rosalie Griffin Waller, BS, Charles Dumontet, James McKay, Kenneth Offit, MD, Siwei Chen, Daniel R O'Brien, S. Vincent Rajkumar, MD, Robert Klein, PhD, Shaji K. Kumar, MD, Steven Lipkin, MD PhD, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2018) 132 (Supplement 1): 4501.

https://doi.org/10.1182/blood-2018-99-119320

Published: 2018

Journal Articles

Association between the Risk of Low/High-Count Monoclonal B-Cell Lymphocytosis (MBL) and the Chronic Lymphocytic Leukemia (CLL) Polygenic Risk Score (PRS)

Geffen Kleinstern, PhD, Sara J. Achenbach, Dennis P. Robinson, Aaron D. Norman, Kari G. Chaffee, MS, Connie E. Lesnick, Sameer A. Parikh, MD, Timothy G. Call, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD, Susan L. Slager, PhD

Blood (2018) 132 (Supplement 1): 5538.

https://doi.org/10.1182/blood-2018-99-116414

Published: 2018

Journal Articles

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Blood (2018) 131 (23): 2541–2551.

https://doi.org/10.1182/blood-2017-11-814608

Published: 2018

Includes: Supplemental data

Journal Articles

Exome Sequencing in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Families Identifies Cosegregating Functional Variants

Sara Beiggi, PhD, Daniel R O'Brien, Sara J Achenbach, Kari G Rabe, MS, Timothy G Call, MD, Neil E Kay, MD, Tait D Shanafelt, MD, Aaron D Norman, MS, Julie M Cunningham, PhD, Vincent Rajkumar, MD, Shaji Kumar, MD, James R Cerhan, MD PhD, Celine M Vachon, PhD, Susan L Slager, PhD

Blood (2014) 124 (21): 1967.

https://doi.org/10.1182/blood.V124.21.1967.1967

Published: 2014

Journal Articles

Interaction of platelet-derived autotaxin with tumor integrin α V β 3 controls metastasis of breast cancer cells to bone

Raphael Leblanc, Sue-Chin Lee, Marion David, Jean-Claude Bordet, Derek D. Norman, Renukadevi Patil, Duane Miller, Debashish Sahay, Johnny Ribeiro, Philippe Clézardin, Gabor J. Tigyi, Olivier Peyruchaud

Blood (2014) 124 (20): 3141–3150.

https://doi.org/10.1182/blood-2014-04-568683

Published: 2014

Includes: Supplemental data

Journal Articles

Production of cytokines by bone marrow cells obtained from patients with multiple myeloma

A Lichtenstein, J Berenson, D Norman, MP Chang, A Carlile

Blood (1989) 74 (4): 1266–1273.

https://doi.org/10.1182/blood.V74.4.1266.1266

Published: 1989

NARROW

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Mosaic Chromosomal Alterations and Monoclonal B-Cell Lymphocytosis: Relationship and Risk of Hematologic Malignancies

Progression and survival of MBL: a screening study of 10 139 individuals

Prevalence and Overall Survival of Low Count Monoclonal B-Cell Lymphocytosis (LC-MBL): A Screening Study of 8,297 Individuals from the Mayo Clinic Biobank

Relationship and Susceptibility to Serious Infections Among Monoclonal B-Cell Lymphocytosis (MBL), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Clonal Hematopoiesis (CH) Premalignant Conditions

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)

Body Mass Index and Clinical Factors Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Progression in Olmsted County, Minnesota

Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)

Large-Scale Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Families

Association between the Risk of Low/High-Count Monoclonal B-Cell Lymphocytosis (MBL) and the Chronic Lymphocytic Leukemia (CLL) Polygenic Risk Score (PRS)

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Exome Sequencing in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Families Identifies Cosegregating Functional Variants

Interaction of platelet-derived autotaxin with tumor integrin α V β 3 controls metastasis of breast cancer cells to bone

Production of cytokines by bone marrow cells obtained from patients with multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only